BIT/1CAH (BIT/1CAH)

Borsa Italiana: BIT/1CAH · EUR

€202

-1.80 (-0.9%)· Recorded snapshot

Market cap	51.2B
Revenue (ttm)	222.5B
Net income (ttm)	1.5B
EPS (ttm)	€6.50
P/E (trailing)	31.0x
P/E (forward)	19.5x
Dividend	€1.79 (0.89%)

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 222.5B
Net income (ttm): 1.5B
EPS (ttm): €6.50
P/E (trailing): 31.0x
P/E (forward): 19.5x
Market cap: 51.2B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E19.5

P25 13.7P50 18.9P75 26.3

Trailing P/E31

P25 18.3P50 24.5P75 35.6

ROEn/a

P25 2.4P50 10.6P75 22.2

ROIC18.4

P25 5.1P50 9P75 18.8

Benchmarks · 1M

All BIT/1CAH indicators

Market & fundamental data

Available fields

225

Groups with data

Currency

USD

Showing 225 of 225 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	United States
Country code	IT
Earnings date	2026-11-05
Employees	63,900
Employees change	6,200
Employees growth	10.75%
Enterprise value	EUR 56B
Exchange	Borsa Italiana
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-10-10
Fiscal year end	June
Founded	1979
Industry	Medical Distribution
Is primary listing	No
ISIN number	US14149Y1082
Last refreshed	2026-10-28
Market cap	EUR 51.2B
Next earnings date	2026-11-05
Price	EUR 201.60
Price currency	EUR
Sector	Healthcare
SIC code	5122
Stock price date	2026-10-02
Symbol	bit/1CAH
Website	https://www.cardinalhealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	181.56x
Average P/E ratio (3Y)	34.74x
Average P/E ratio (5Y)	35.65x
Earnings yield	3.22%
EV/Earnings	37.31x
EV/EBIT	18.97x
EV/EBITDA	13.74x
EV/FCF	14.13x
EV/Sales	0.25x
FCF / EV yield	7.08%
FCF yield	7.73%
Forward P/E	19.5x
Lynch fair value	EUR 135.30
Lynch upside	-32.89%
P/(FCF - SBC) ratio	14.07x
P/(OCF - SBC) ratio	12.17x
P/E ratio	31.01x
P/FCF ratio	12.93x
P/OCF ratio	11.31x
P/S ratio	0.23x
Price/EBITDA ratio	13.79x
Sector forward P/E	16.78x
Sector P/E	20.93x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	1.29%
EBITDA margin	1.67%
Effective tax rate	21.57%
FCF margin	1.73%
Gross margin	3.84%
Operating margin	1.29%
Pretax margin	0.86%
Profit margin	0.67%
Profit per employee	EUR 24,457
Profitable quarters	11
Profitable years	4
Revenue per employee	EUR 3.6M
ROA	3.72%
ROA (5Y)	2.96%
ROCE	24.55%
ROIC	18.36%
ROIC (5Y)	15.17%
SBC / revenue	0.14%
Tax / revenue	0.18%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	12.09%
EPS growth (Q)	68.8%
EPS growth (QoQ)	-0.54%
EPS growth 10Y	5.28%
EPS growth 3Y	79.03%
EPS growth 5Y	28.3%
EPS growth quarters	1
EPS growth years	4
FCF growth	144.6%
FCF growth (Q)	10.87%
FCF growth (QoQ)	-14.85%
FCF growth 3Y	24.18%
FCF growth 5Y	17.4%
Gross profit growth	19.66%
Gross profit growth (Q)	16.26%
Gross profit growth 3Y	12.45%
Gross profit growth 5Y	7.6%
Net income growth	9.8%
Net income growth (Q)	66.53%
Net income growth (QoQ)	-0.25%
Net income growth 3Y	73.18%
Net income growth 5Y	22.91%
Net income growth quarters	1
Net income growth years	4
OCF growth	115.85%
OCF growth (Q)	11.32%
OCF growth (QoQ)	-7.19%
OCF growth 10Y	5.7%
OCF growth 3Y	22.08%
OCF growth 5Y	16.33%
Operating income growth	32.26%
Operating income growth (Q)	34.02%
Operating income growth 3Y	22.49%
Operating income growth 5Y	12.88%
Revenue growth	14.23%
Revenue growth (Q)	5.84%
Revenue growth (QoQ)	4.48%
Revenue growth 10Y	7.66%
Revenue growth 3Y	7.44%
Revenue growth 5Y	9.37%
Revenue growth quarters	6
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -568.1M
Depreciation and amortization	EUR 859.5M
EBIT	EUR 2.9B
EBITDA	EUR 3.7B
EPS	EUR 6.50
Financing cash flow	EUR -1.4B
Free cash flow	EUR 4B
Free cash flow minus SBC	EUR 3.6B
Gross profit	EUR 8.6B
Income taxes	EUR 410.5M
Investing cash flow	EUR -2.3B
Net borrowing	EUR 303M
Net cash flow	EUR 859.5M
Net income	EUR 1.5B
Operating cash flow minus SBC	EUR 4.2B
Operating income	EUR 2.9B
Revenue	EUR 222.5B
Stock-based compensation	EUR 321.2M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	5.02
Book value per share	EUR -10.83
Debt / EBITDA	2.2
Debt / FCF	2.21
Goodwill	EUR 10.3B
Interest coverage	9.45
Long-term assets	EUR 15.3B
Long-term liabilities	EUR 13.1B
Net cash (debt)	EUR -4.5B
Net cash / market cap	-8.79%
Net debt / EBITDA	1.21
Net debt / FCF	1.14
Piotroski F-Score	7
Property, plant and equipment	EUR 3.6B
Shareholders' equity	EUR -2.4B
Tangible book value	EUR -14.5B
Tangible book value per share	EUR -62.04
Total assets	EUR 50.2B
Total cash	EUR 4.3B
Total debt	EUR 8.8B
Total liabilities	EUR 52.5B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	4.61
Current assets	EUR 34.8B
Current liabilities	EUR 39.5B
Current ratio	0.88
Inventory turnover	14.33
Net working capital	EUR -6.9B
Quick ratio	0.43
Working capital	EUR -4.5B
Working capital turnover	-57.99

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	2.07%
Dividend growth	0%
Dividend growth years	0
Dividend payment date	2026-10-15
Dividend payment years	3
Dividend payout frequency	Quarterly
Dividend per share	EUR 1.79
Dividend yield	0.89%
Ex-dividend date	2026-09-30
Last dividend	EUR 0.46
Payout ratio	28.65%
Shareholder yield	2.95%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 190.84
1D price change	-0.88%
1M price change	-2.37%
1M total return	-2.14%
1W price change	4.21%
1W total return	4.46%
1Y price change	49.11%
1Y return CAGR	50.57%
1Y total return	50.52%
20-day SMA	EUR 200.41
200-day SMA	EUR 188.77
3M price change	-3.08%
3M total return	-2.85%
50-day SMA	EUR 202.22
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 217.50
52-week high date	2026-06-30
52-week low	EUR 131.10
52-week low date	2025-10-13
6M price change	10.41%
6M total return	10.9%
All-time high	EUR 217.50
All-time high date	2026-06-30
All-time low	EUR 119.35
All-time low date	2025-04-28
Average true range (ATR)	EUR 2.14
Average volume	0.5
Change from 52-week high	-7.31%
Change from 52-week low	53.78%
Change from all-time high	-7.31%
Change from all-time low	68.91%
Change from open	0%
Day's gap	-0.88%
High price	EUR 201.60
Low price	EUR 201.60
Monthly RSI	70.79
Open price	EUR 201.60
Previous close	EUR 203.40
Price vs 150-day SMA	5.64%
Price vs 20-day SMA	0.59%
Price vs 200-day SMA	6.8%
Price vs 50-day SMA	-0.3%
RSI	52.29
Sharpe ratio	1.19
Sortino ratio	2.26
Weekly RSI	55.21
YTD price change	13.58%
YTD total return	14.65%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	231.1M
Shares change (QoQ)	-0.42%
Shares change (YoY)	-2.07%
Shares held by insiders	0.08%
Shares held by institutions	90.6%
Short ratio	4.2 days

Deeper analysis on BIT/1CAH

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BIT/1CAH report

Is a complete BIT/1CAH research report available?

No complete published report is available for bit/1CAH (BIT/1CAH) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BIT/1CAH (BIT/1CAH)

Price

Financial snapshot

Fair-value bridge

Latest news · BIT/1CAH

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BIT/1CAH indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BIT/1CAH

Frequently asked questions